Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
As a result, delivery within 2 business days is not guaranteed
Market exclusivity and patent protections Global distribution and local regulations Insurance coverage and reimbursement policies Manufacturers pricing strategy and supply chain costs Market competition and alternative therapies Retatrutide will almost certainly be deemed a high-cost drug, given its expected price range and comparability to other state-of-the-art weight-loss or metabolic medications
The trial was published in the New England Journal of Medicine
Its GLP-1 market, valued at about $1.7 billion in 2023 according to Clarivate, is expected to grow as the number of obesity patients is projected to exceed 500 million by 2033
US$ 28.26
US$ 28.02
US$ 24.30
US$ 26.79
US$ 21.67
